These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10534420)

  • 1. Exogenous calcium preconditions myocardium from patients taking oral sulfonylurea agents.
    Cain BS; Meldrum DR; Meng X; Pulido EJ; Shames BD; Selzman CH; Banerjee A; Harken AH
    J Surg Res; 1999 Oct; 86(2):171-6. PubMed ID: 10534420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic antidysrhythmic and functional protection in human atria.
    Cain BS; Meldrum DR; Meng X; Pulido EJ; Banerjee A; Harken AH
    J Surg Res; 1998 May; 76(2):143-8. PubMed ID: 9698514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical L-type Ca(2+) channel blockade prevents ischemic preconditioning of human myocardium.
    Cain BS; Meldrum DR; Cleveland JC; Meng X; Banerjee A; Harken AH
    J Mol Cell Cardiol; 1999 Dec; 31(12):2191-7. PubMed ID: 10640446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine reduces cardiac TNF-alpha production and human myocardial injury following ischemia-reperfusion.
    Cain BS; Meldrum DR; Dinarello CA; Meng X; Banerjee A; Harken AH
    J Surg Res; 1998 May; 76(2):117-23. PubMed ID: 9698510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium preconditioning, but not ischemic preconditioning, bypasses the adenosine triphosphate-dependent potassium (KATP) channel.
    Meldrum DR; Cain BS; Meng X; Cleveland JC; Shames BD; Donnahoo KK; Banerjee A; Harken AH
    J Surg Res; 1999 Jul; 85(1):77-82. PubMed ID: 10383841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine preconditioning reduces both pre and postischemic arrhythmias in human myocardium.
    Pomerantz BJ; Joo K; Shames BD; Cleveland JC; Banerjee A; Harken AH
    J Surg Res; 2000 May; 90(2):191-6. PubMed ID: 10792962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited.
    Cleveland JC; Meldrum DR; Cain BS; Banerjee A; Harken AH
    Circulation; 1997 Jul; 96(1):29-32. PubMed ID: 9236412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium.
    Pomerantz BJ; Robinson TN; Morrell TD; Heimbach JK; Banerjee A; Harken AH
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):387-92. PubMed ID: 10917958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective mitochondrial KATP channel opening controls human myocardial preconditioning: too much of a good thing?
    Pomerantz BJ; Robinson TN; Heimbach JK; Calkins CM; Miller SA; Banerjee A; Harken AH
    Surgery; 2000 Aug; 128(2):368-73. PubMed ID: 10923018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 MAPK inhibition decreases TNF-alpha production and enhances postischemic human myocardial function.
    Cain BS; Meldrum DR; Meng X; Dinarello CA; Shames BD; Banerjee A; Harken AH
    J Surg Res; 1999 May; 83(1):7-12. PubMed ID: 10210635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postconditioning protects human atrial muscle through the activation of the RISK pathway.
    Sivaraman V; Mudalagiri NR; Di Salvo C; Kolvekar S; Hayward M; Yap J; Keogh B; Hausenloy DJ; Yellon DM
    Basic Res Cardiol; 2007 Sep; 102(5):453-9. PubMed ID: 17546527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium preconditioning in human myocardium.
    Cain BS; Meldrum DR; Meng X; Shames BD; Banerjee A; Harken AH
    Ann Thorac Surg; 1998 Apr; 65(4):1065-70. PubMed ID: 9564929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits.
    Nieszner E; Posa I; Kocsis E; Pogátsa G; Préda I; Koltai MZ
    Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):212-8. PubMed ID: 12148084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning and hypothermic cardioplegia protect human heart equally against ischemia.
    Cleveland JC; Meldrum DR; Rowland RT; Banerjee A; Harken AH
    Ann Thorac Surg; 1997 Jan; 63(1):147-52. PubMed ID: 8993257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue.
    Rosenfeldt F; Marasco S; Lyon W; Wowk M; Sheeran F; Bailey M; Esmore D; Davis B; Pick A; Rabinov M; Smith J; Nagley P; Pepe S
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):25-32. PubMed ID: 15632821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity.
    Kaljusto ML; Stensløkken KO; Mori T; Panchenko A; Frantzen ML; Valen G; Vaage J
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):355-63. PubMed ID: 18221880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
    Fisman EZ; Tenenbaum A; Motro M; Adler Y
    Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.